MedTrace Logo

Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD

NCT03370744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-09-08

No results posted yet for this study

Summary

This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. To establish models of normal and pathological cognitive aging.To collect the longitudinal data of SCD population, to study the dynamic changes of brain networks so as to explore the progressive mechanisms of AD on brain networks and to construct a high-precision multi-modal model for early diagnosis.

Conditions

  • Subjective Cognitive Decline
  • Preclinical Alzheimer's Disease

Interventions

DIAGNOSTIC_TEST

Neuropsychological scale

Neuropsychological scale, including mini-mental state examination (MMSE), Montreal cognitive assessment (MoCA), clinical dementia rating scales (CDR) and so on

Sponsors & Collaborators

  • XuanwuH 2

    lead OTHER

Principal Investigators

  • Ying Han, Doctor · Xuanwu Hospitial Capital Medical University

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2020-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03370744 on ClinicalTrials.gov